Your session is about to expire
← Back to Search
Behavioral Intervention
Text Message Reminders for Pediatric COVID-19 and Flu Vaccines
N/A
Waitlist Available
Led By Alex Fiks, MD MSCE
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up ~7 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is looking at how text message reminders can help people get their COVID-19 and flu vaccines. It is being done in various pediatric practices associated with the American Academy of Pediatrics.
Who is the study for?
This trial is for parents or guardians of children eligible to receive COVID-19 and influenza vaccines. It's focused on those who are part of the AAP PROS network practices, aiming to see if text reminders can improve vaccination rates.
What is being tested?
The study tests whether sending text message reminders can increase the number of kids getting their flu and COVID-19 shots. Different groups will get reminders for just one vaccine or both, to compare effectiveness.
What are the potential side effects?
Since this trial involves sending text messages as a reminder, there are no direct medical side effects associated with the interventions being tested.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ ~7 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~~7 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Percentage of Participants Who Received COVID-19 Vaccine by April 30 Each Year
Percentage of Participants Who Received COVID-19 Vaccine by December 31 Each Year
Percentage of Participants Who Received Influenza Vaccine by April 30 Each Year
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Text message influenza vaccine remindersExperimental Treatment1 Intervention
Text message reminders only for influenza vaccination
Group II: Text message influenza and COVID-19 vaccine remindersExperimental Treatment1 Intervention
Text message reminders for both influenza and COVID-19 vaccinations
Group III: Text message COVID-19 vaccine remindersExperimental Treatment1 Intervention
Text message reminders only for COVID-19 vaccination
Group IV: Usual CareActive Control1 Intervention
Usual care has no text message
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Text message influenza vaccine reminders
2017
N/A
~2110
Find a Location
Who is running the clinical trial?
University of PennsylvaniaOTHER
2,084 Previous Clinical Trials
42,676,533 Total Patients Enrolled
American Academy of PediatricsOTHER
44 Previous Clinical Trials
1,021,091 Total Patients Enrolled
Columbia UniversityLead Sponsor
1,498 Previous Clinical Trials
2,718,981 Total Patients Enrolled
National Institute of Allergy and Infectious Diseases (NIAID)NIH
3,336 Previous Clinical Trials
5,342,834 Total Patients Enrolled
Children's Hospital of PhiladelphiaOTHER
731 Previous Clinical Trials
8,422,319 Total Patients Enrolled
Alex Fiks, MD MSCEPrincipal InvestigatorChildren's Hospital of Philadelphia
Melissa Stockwell, MD MPHPrincipal InvestigatorColumbia University
13 Previous Clinical Trials
30,924 Total Patients Enrolled